U.S. economy expanded 3.3% in Q2, with growth even stronger than initially thought

U.S. economy expanded 3.3% in Q2, with growth even stronger than initially thought


A shopper holds Macy’s bags outside the company’s flagship store in the Herald Square neighborhood of New York, July 15, 2025.

Alan Chin | Bloomberg | Getty Images

The U.S. economy grew at a pace that was faster than expected in the second quarter as consumers and businesses held up against tariff volatility.

Gross domestic product rose at a 3.3% annualized pace in the April-through-June period, the Commerce Department reported Thursday in its second estimate for the most encompassing measure of economic activity. The reading was better than an initial 3.0% estimate as well as the 3.1% Dow Jones consensus forecast.

Consumer spending, which rose by 1.6% compared with an initial 1.4% estimate, helped push the number higher.

Importantly, a measure called final sales to private domestic purchasers jumped 1.9%, up from the previous figure of 1.2%. Federal Reserve officials watch that metric closely as an indication of demand and sales that focuses on activity within U.S. borders, an especially important measure considering the uncertain impact of President Donald Trump’s tariffs.

The GDP number also reflected the unusual impact of the tariffs as they related to trade numbers.

Imports, which subtract from GDP, tumbled 29.8% in the quarter after companies stockpiled ahead of Trump’s April 2 “liberation day” announcement. The figure was a bit less than the previous estimate of 30.3%.

At the same time, exports, which add to GDP, fell by 1.3%, compared with the previous estimate of -1.8%. Taking the figures together, net exports added nearly 5 percentage points to the Q2 total.

For the first half of the year, GDP has grown about 2.1%, or an average of a little more than 1% per quarter. The economy contracted 0.5% in the first quarter, largely due to the impact of the import rush.

“The good news is consumption came in higher than previously thought. Americans are continuing to spend despite the tariffs and uncertainty, albeit at a slower pace than past years,” said Heather Long, chief economist at Navy Federal Credit Union. “Going forward, the economy is likely to stay in this slower speed mode with spending and growth around 1.5% as the tariffs become more visible to American consumers.”

With the first months’ data mostly in the books, the economy is growing at a 2.2% pace in the third quarter, according to the Atlanta Fed’s GDPNow measure.

Inflation-related estimates were little changed from the initial reading. Core personal consumption expenditures prices, which exclude the volatile food and energy categories, rose 2.5%, unchanged from the prior figure, while the headline PCE price index edged lower to 2%, in line with the Fed’s inflation goal.



Source

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now
World

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now

Tiina Lee, the CEO of Citi U.K., expects global growth to remain resilient this year, telling CNBC that a “recessionary environment” is “not our base case.” Markets have continued to perform in an orderly way, despite the economic and geopolitical upheaval caused by the Iran conflict, which entered its 60th day on Tuesday, Lee said. […]

Read More
‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More